This book offers a foundational understanding, along with advancements in diagnostics and treatments for melanoma. It underscores the importance of integrating multi-omics approaches for a holistic understanding and explores combination therapies for improving treatment.
This book offers a foundational understanding, along with advancements in diagnostics and treatments for melanoma. It underscores the importance of integrating multi-omics approaches for a holistic understanding and explores combination therapies for improving treatment.
Zodwa Dlamini is a Professor of Molecular Oncology and the founding Director and the Executive Head of the Pan African Cancer Research Institute (PACRI) in South Africa. She is the Director of South African Medical Research Council (SAMRC) Precision Oncology Research Unit (PORU). She is the DSTI/NRF SARChI Chair in Precision Oncology and Cancer Prevention (POCP). She is a member of the American Association for Cancer Research (AACR) Advisory Group on Sub-Saharan Africa. She is a member of the AACR Pathology Resources in Africa Advisory Group. Professor Dlamini is a member of the African Organisation for Research and Training in Cancer (AORTIC) Research Committee Scientific Advisory Board. She is an elected member of the Academy of Science of South Africa. Professor Dlamini is an overseas Fellow of the Royal Society of Medicine (London) and a member of the New York Academy of Sciences.
Inhaltsangabe
1. Understanding Melanoma: From Basics to Cutting-Edge Insights2. Molecular Profiling in Melanoma: Precision Strategies for Targeted Therapies3. Artificial Intelligence in Melanoma Diagnostics: Revolutionizing Detection and Diagnosis4. Immunotherapy Advancements: Harnessing the Immune System with Technological Precision5. Targeted Therapies and Nanomedicine: Precision at the Molecular Level6. Overcoming Resistance: Molecular Insights and Therapeutic Options7. Integrating Genomics and Proteomics: A Multi-Omics Approach to Melanoma Treatment8. Next-Generation Imaging Technologies: Revolutionizing Melanoma Monitoring and Assessment9. Patient-Centric Technologies: Empowering Individuals in Melanoma Care10. Unveiling Synergistic Future Horizons in Melanoma Combination Therapies11. Collaborative Solutions for Future Challenges in Melanoma: A Technological Roadmap12. Conclusion and Future Directions in Melanoma Treatment
1. Understanding Melanoma: From Basics to Cutting-Edge Insights2. Molecular Profiling in Melanoma: Precision Strategies for Targeted Therapies3. Artificial Intelligence in Melanoma Diagnostics: Revolutionizing Detection and Diagnosis4. Immunotherapy Advancements: Harnessing the Immune System with Technological Precision5. Targeted Therapies and Nanomedicine: Precision at the Molecular Level6. Overcoming Resistance: Molecular Insights and Therapeutic Options7. Integrating Genomics and Proteomics: A Multi-Omics Approach to Melanoma Treatment8. Next-Generation Imaging Technologies: Revolutionizing Melanoma Monitoring and Assessment9. Patient-Centric Technologies: Empowering Individuals in Melanoma Care10. Unveiling Synergistic Future Horizons in Melanoma Combination Therapies11. Collaborative Solutions for Future Challenges in Melanoma: A Technological Roadmap12. Conclusion and Future Directions in Melanoma Treatment
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826